Comparison of major definitions of sarcopenia based on the skeletal muscle index in patients with urothelial carcinoma

Inconsistencies in currently used definitions of sarcopenia in oncology

(2020) S. Taguchi et al.   ANNALS OF ONCOLOGY

Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy

(2019) Yoshitaka Itami et al.   International Journal of Clinical Oncology

Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

(2019) Timothy D. Lyon et al.   Clinical Genitourinary Cancer

Sarcopenia as a significant predictive factor of neutropenia and overall survival in urothelial carcinoma patients underwent gemcitabine and cisplatin or carboplatin

(2019) Tetsuya Yumioka et al.   International Journal of Clinical Oncology

Skeletal Muscle and Fat Mass Indexes Predict Discharge Disposition after Radical Cystectomy

(2019) Jacob Albersheim et al.   JOURNAL OF UROLOGY

Decrease in skeletal muscle index one year after radical cystectomy as a prognostic indicator in patients with urothelial bladder cancer

(2019) Yun-Sok Ha et al.   International Braz J Urol

Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy?

(2018) Neil J. Kocher et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy

(2018) Hiroshi Fukushima et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer

(2018) Roman Mayr et al.   WORLD JOURNAL OF UROLOGY

Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer

(2018) Roman Mayr et al.   Journal of Cachexia Sarcopenia and Muscle

OUP accepted manuscript

(2018)   AGE AND AGEING

Implications of low muscle mass across the continuum of care: a narrative review

(2018) Carla M. Prado et al.   ANNALS OF MEDICINE

Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer

(2018) et al.   UROLOGIA INTERNATIONALIS

Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial

(2018) Chad R. Ritch et al.   JOURNAL OF UROLOGY

Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder

(2018) Judith Stangl-Kremser et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy

(2017) Hideyuki Abe et al.   International Journal of Clinical Oncology

Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy

(2017) Makito Miyake et al.   ONCOLOGY

A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy

(2017) Yoko Saitoh-Maeda et al.   BMC Urology

A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy

(2017) Ryo Kasahara et al.   Biomed Research International

Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy

(2016) Yosuke Hirasawa et al.   ANNALS OF SURGICAL ONCOLOGY

Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma

(2016) Satoru Taguchi et al.   Clinical Genitourinary Cancer

Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review

(2016) Shlomit Strulov Shachar et al.   EUROPEAN JOURNAL OF CANCER

Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study

(2016) Hiroki Ishihara et al.   International Journal of Clinical Oncology

Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults

(2016) Yuhei Hamaguchi et al.   NUTRITION

Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy

(2016) Hiroshi Fukushima et al.   Cancer Medicine

Mortality after Radical Cystectomy: Impact of Obesity Versus Adiposity after Adjusting for Skeletal Muscle Wasting

(2015) Sarah P. Psutka et al.   JOURNAL OF UROLOGY

Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma

(2015) Hiroshi Fukushima et al.   PLoS One

Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality

(2014) Sarah P. Psutka et al.   CANCER

Sarcopenia as a Predictor of Complications and Survival Following Radical Cystectomy

(2014) Angela B. Smith et al.   JOURNAL OF UROLOGY

Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer

(2014) Fangning Wan et al.   World Journal of Surgical Oncology

Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index

(2013) Lisa Martin et al.   JOURNAL OF CLINICAL ONCOLOGY

Definition and classification of cancer cachexia: an international consensus

(2011) Kenneth Fearon et al.   LANCET ONCOLOGY

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

(2010) A. J. Cruz-Jentoft et al.   AGE AND AGEING

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

(2010) S. Antoun et al.   ANNALS OF ONCOLOGY

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

(2008) Carla MM Prado et al.   LANCET ONCOLOGY